Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Myxoid Liposarcomas: Systemic Treatment Options.
Nassif EF, Keung EZ, Thirasastr P, Somaiah N. Nassif EF, et al. Among authors: thirasastr p. Curr Treat Options Oncol. 2023 Apr;24(4):274-291. doi: 10.1007/s11864-023-01057-4. Epub 2023 Feb 28. Curr Treat Options Oncol. 2023. PMID: 36853469 Review.
The immune landscape of undifferentiated pleomorphic sarcoma.
Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. Lazcano R, et al. Among authors: thirasastr p. Front Oncol. 2022 Oct 12;12:1008484. doi: 10.3389/fonc.2022.1008484. eCollection 2022. Front Oncol. 2022. PMID: 36313661 Free PMC article.
New Drug Approvals for Sarcoma in the Last 5 Years.
Thirasastr P, Brahmi M, Dufresne A, Somaiah N, Blay JY. Thirasastr P, et al. Surg Oncol Clin N Am. 2022 Jul;31(3):361-380. doi: 10.1016/j.soc.2022.03.003. Surg Oncol Clin N Am. 2022. PMID: 35715139 Review.
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma.
Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Thirasastr P, et al. Cancer Med. 2023 Feb;12(4):4282-4293. doi: 10.1002/cam4.5298. Epub 2022 Sep 24. Cancer Med. 2023. PMID: 36151848 Free PMC article.
Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center.
Nassif EF, Cope B, Traweek R, Witt RG, Erstad DJ, Scally CP, Thirasastr P, Zarzour MA, Ludwig J, Benjamin R, Bishop AJ, Guadagnolo BA, Ingram D, Wani K, Wang WL, Lazar AJ, Torres KE, Hunt KK, Feig BW, Roland CL, Somaiah N, Keung EZ. Nassif EF, et al. Among authors: thirasastr p. Int J Cancer. 2022 Jun 15;150(12):2012-2024. doi: 10.1002/ijc.33956. Epub 2022 Feb 18. Int J Cancer. 2022. PMID: 35128664 Free article.
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Thirasastr P, Sutton TL, Joseph CP, Lin H, Amini B, Mayo SC, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Nassif Haddad EF, Nakazawa MS, Zhou X, Heinrich MC, Somaiah N. Thirasastr P, et al. Cancers (Basel). 2024 Feb 23;16(5):904. doi: 10.3390/cancers16050904. Cancers (Basel). 2024. PMID: 38473266 Free PMC article.
Feasibility Technique of Low-passage In Vitro Drug Sensitivity Testing of Malignant Pleural Effusion from Advanced-stage Non-small Cell Lung Cancer for Prediction of Clinical Outcome.
Vinayanuwattikun C, Prakhongcheep O, Tungsukruthai S, Petsri K, Thirasastr P, Leelayuwatanakul N, Chanvorachote P. Vinayanuwattikun C, et al. Among authors: thirasastr p. Anticancer Res. 2019 Dec;39(12):6981-6988. doi: 10.21873/anticanres.13920. Anticancer Res. 2019. PMID: 31810970